Research use only
Kovalabs supplies research-grade peptides to qualified researchers for laboratory use only. They are not medicines, are not for human or animal consumption, and are supplied with no dosing or medical guidance.
You must be 18 or over and a qualified person purchasing solely for scientific research.
Selecting ‘I agree’ confirms the above and your acceptance of our Research Disclaimer and Terms of Sale.
Manufactured for laboratory research. Not for human or veterinary use. Read full disclaimer →
AOD-9604 is a synthetic peptide fragment of the C-terminal region (residues 176-191) of human growth hormone, studied in research for its lipolytic and metabolic-pathway activity in experimental models.
AOD-9604 is a synthetic peptide based on the C-terminal region of human growth hormone, specifically a tyrosine-bearing analogue of the 176-191 fragment (Tyr-hGH 177-191). It carries the molecular formula C78H123N23O23S2, a molecular weight of 1815.1 g/mol, and the CAS number 221231-10-3. Kovalabs supplies it as a lyophilised research material.
Because it is a structural relative of HGH Fragment 176-191, AOD-9604 is sometimes catalogued alongside it as a reference standard. It is a research chemical only and is not a medicine.
AOD-9604 is not a controlled drug under the Misuse of Drugs Act 1971, and it is not a licensed medicine in the UK. Kovalabs supplies it strictly as a research material for laboratory use, not for human or veterinary consumption. It must not be administered to people or animals. Purchasers are responsible for complying with the laws and institutional rules that apply to handling research chemicals in their jurisdiction.
Every batch is released only after independent analytical testing. Purity is assessed by HPLC at 99% or higher, and identity is confirmed against the expected mass and the verified identifiers: CAS 221231-10-3, PubChem CID 71300630, and molecular formula C78H123N23O23S2. Because quality varies between suppliers, a Certificate of Analysis documents these results so the material can be verified before use in research. You can review our published records on the CoA page.
The published literature investigates AOD-9604 as a fragment-derived peptide in pre-clinical metabolic-pathway studies, conducted in vitro and in animal models. None of this establishes any benefit, effect or outcome in humans, and AOD-9604 is not a licensed medicine. For a referenced overview of the study designs and pathways involved, see the AOD-9604 research monograph. Full terms are set out in our research disclaimer.
AOD-9604 is manufactured by solid-phase peptide synthesis and supplied as a white to off-white lyophilised powder. For laboratory handling it is typically reconstituted with bacteriostatic water and held at 2-8C once in solution; the sealed lyophilised vial is stored at -20C, dry and protected from light. It sits within our metabolic research category alongside related materials such as MOTS-c and Cagrilintide. Supplied for laboratory research use only; not for human or veterinary use.
No third-party batch reports have been uploaded for this product yet. Reports are issued by independent labs after each manufacturing batch.
Store unreconstituted vials at -20°C for long-term, or refrigerated at 2-8°C for short-term use. Avoid repeated freeze-thaw cycles.
Reconstitute with bacteriostatic water down the inside wall of the vial; gently swirl to dissolve. Do not shake.
Once reconstituted, refrigerate at 2-8°C and use within 2-4 weeks. Discard if cloudy, discoloured, or particulate.
Pairs with this
Month or so in. Asked Taylor a quick question before ordering and got a straight answer, no sales waffle. Checked a COA against the batch label once out of nosiness and it matched. Highly recommend.